Germany · Delayed Price · Currency is EUR Regeneron Pharmaceuticals Statistics
Total Valuation
FRA:RGO has a market cap or net worth of EUR 50.39 billion. The enterprise value is 37.34 billion.
| Market Cap | 50.39B |
| Enterprise Value | 37.34B |
Important Dates
The last earnings date was Friday, August 1, 2025.
| Earnings Date | Aug 1, 2025 |
| Ex-Dividend Date | May 20, 2025 |
Share Statistics
| Current Share Class | 103.85M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.73% |
| Shares Change (QoQ) | -2.34% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 99.89M |
Valuation Ratios
The trailing PE ratio is 13.27 and the forward PE ratio is 15.54.
| PE Ratio | 13.27 |
| Forward PE | 15.54 |
| PS Ratio | 4.16 |
| PB Ratio | 1.98 |
| P/TBV Ratio | 2.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 9.84 |
| EV / Sales | 3.01 |
| EV / EBITDA | 9.52 |
| EV / EBIT | 10.71 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.39, with a Debt / Equity ratio of 0.09.
| Current Ratio | 5.39 |
| Quick Ratio | 4.73 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.60 |
| Debt / FCF | n/a |
| Interest Coverage | 108.92 |
Financial Efficiency
Return on equity (ROE) is 15.34% and return on invested capital (ROIC) is 7.84%.
| Return on Equity (ROE) | 15.34% |
| Return on Assets (ROA) | 6.71% |
| Return on Invested Capital (ROIC) | 7.84% |
| Return on Capital Employed (ROCE) | 11.96% |
| Revenue Per Employee | 798,482 |
| Profits Per Employee | 250,462 |
| Employee Count | 15,106 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 2.36 |
Taxes
In the past 12 months, FRA:RGO has paid 354.39 million in taxes.
| Income Tax | 354.39M |
| Effective Tax Rate | 8.54% |
Stock Price Statistics
The stock price has decreased by -51.32% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -51.32% |
| 50-Day Moving Average | 463.83 |
| 200-Day Moving Average | 609.16 |
| Relative Strength Index (RSI) | 48.08 |
| Average Volume (20 Days) | 10 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:RGO had revenue of EUR 12.10 billion and earned 3.80 billion in profits. Earnings per share was 33.78.
| Revenue | 12.10B |
| Gross Profit | 5.99B |
| Operating Income | 3.39B |
| Pretax Income | 4.15B |
| Net Income | 3.80B |
| EBITDA | 3.82B |
| EBIT | 3.39B |
| Earnings Per Share (EPS) | 33.78 |
Balance Sheet
The company has 14.92 billion in cash and 2.30 billion in debt, giving a net cash position of 12.62 billion.
| Cash & Cash Equivalents | 14.92B |
| Total Debt | 2.30B |
| Net Cash | 12.62B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.49B |
| Book Value Per Share | 242.56 |
| Working Capital | 18.27B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 49.47%, with operating and profit margins of 28.05% and 31.37%.
| Gross Margin | 49.47% |
| Operating Margin | 28.05% |
| Pretax Margin | 34.30% |
| Profit Margin | 31.37% |
| EBITDA Margin | 31.58% |
| EBIT Margin | 28.05% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.63, which amounts to a dividend yield of 0.34%.
| Dividend Per Share | 1.63 |
| Dividend Yield | 0.34% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.73% |
| Shareholder Yield | 2.06% |
| Earnings Yield | 7.53% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |